Masimo Corporation (NASDAQ:MASI) Receives $180.40 Average PT from Analysts

Posted by Brian Himes on May 21st, 2026

Shares of Masimo Corporation (NASDAQ:MASI – Get Free Report) have earned a consensus rating of “Hold” from the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a hold rating. The average 12 month target price among analysts that have issued a report on the stock in the last year is $180.40.

A number of research analysts have issued reports on the stock. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a report on Tuesday, February 17th. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Raymond James Financial cut shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Finally, Wells Fargo & Company raised shares of Masimo to a “hold” rating in a report on Wednesday, March 18th.

Get Our Latest Stock Analysis on Masimo

Masimo Trading Down 0.0%

NASDAQ MASI opened at $178.79 on Friday. The stock has a market capitalization of $9.36 billion, a P/E ratio of -16.96, a P/E/G ratio of 1.81 and a beta of 1.13. Masimo has a 52-week low of $125.94 and a 52-week high of $179.00. The firm has a 50-day moving average price of $177.99 and a 200 day moving average price of $156.67. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC purchased a new position in Masimo in the fourth quarter valued at about $27,000. Aster Capital Management DIFC Ltd purchased a new position in Masimo in the fourth quarter valued at about $28,000. Los Angeles Capital Management LLC purchased a new position in Masimo in the fourth quarter valued at about $31,000. Western Wealth Management LLC acquired a new stake in shares of Masimo in the first quarter valued at approximately $44,000. Finally, Rothschild Investment LLC grew its position in shares of Masimo by 12,950.0% in the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 259 shares during the last quarter. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Company Profile

(Get Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.